Signs of progress against the superbugs, but not yet at the scale needed: Study
Express Pharma covers the top insights from the 2020 Antimicrobial Resistance Benchmark.
The article dives into the results of the second Antimicrobial Resistance Benchmark, covering topics like antibacterial R&D, forgotten antibiotics, progress in responsible promotion, and tracking the spread of resistance.
The article highlights that while progress can be seen, change is not happening at the scale needed to radically impact the threat from drug resistance.